The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

UK shareholder meetings calendar - next 7 days

Mon, 22nd Mar 2021 15:58

Tuesday 23 March 
Blackrock North American Income Trust PLCAGM
Crest Nicholson Holdings PLCAGM
Quartix Holdings PLCAGM
Secured Income Fund PLCGM re B share scheme
Standard Life Private Equity Trust PLCAGM
Wednesday 24 March 
Arden Partners PLCAGM
BlackRock Throgmorton Trust PLCAGM
Mitchells & Butlers PLCAGM
N4 Pharma PLCAGM
Oxford Biodynamics PLCAGM
Pantheon Resources PLCAGM
Rights & Issues Investment Trust PLCAGM
Tertiary Minerals PLCGM re disapplying pre-emptive rights
Thursday 25 March 
Emmerson PLCGM re move to AIM from main market
Micro Focus International PLCAGM
SSP Group PLCAGM
Xeros Technology PLCGM re shareholders approval for AIM trading
Friday 26 March 
Beazley PLCAGM
Jupiter UK Growth Investment Trust PLCGM re liquidation
Kape Technologies PLCGM re consideration shares issue
PCF Group PLCAGM
Sigma Capital Group PLCAGM
Monday 29 March 
Aukett Swanke Group PLCAGM
Sabien Technology Group PLCAGM
WANdisco PLCGM re proposed fundraising by way of subscription
Nuformix PLCAGM
Pathfinder Minerals PLCGM re fundraising
TOC Property Backed Lending Trust PLCGM re dividend policy
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
12 Mar 2024 14:30

UK shareholder meetings calendar - next 7 days

1 Mar 2024 10:31

IN BRIEF: Nuformix announces subscription to raise GBP150,000

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross proceeds of GBP...

3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months th...

23 Oct 2023 12:38

Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002

(Alliance News) - Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatment for idiopath...

18 Sep 2023 10:20

IN BRIEF: Nuformix to receive milestone payments from Oxilio pact

Nuformix PLC - London-based pharmaceutical development company targeting unmet medical needs in fibrosis and oncology - Says it will receive immediate...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.